RCKT
Closed
Rocket Pharmaceuticals Inc
2.59
+0.14 (+5.71%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 2.45
Day's Range: 2.4 - 2.715
Send
sign up or login to leave a comment!
When Written:
16.77
Rocket Pharmaceuticals Inc is a clinical-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The company was founded in 2015 and is headquartered in New York City. Rocket Pharmaceuticals' pipeline includes gene therapies for several rare diseases, including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The company's lead product candidate, RP-L102, is a gene therapy for Fanconi Anemia, which is currently in Phase 1/2 clinical trials. Rocket Pharmaceuticals' mission is to bring hope to patients and families affected by rare diseases through the development of innovative gene therapies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








